Craig Portell
0000-0002-9487-8345
University of Virginia
54 papers found
Refreshing results…
Recent developments in the implementation of novel designs for early-phase combination studies
Clinical Characteristics of 95 Patients With Ocular Adnexal and Uveal Lymphoma: Treatment Outcomes in Extranodal Marginal Zone Subtype
Uveal Lymphoma: Clinical Features, Diagnostic Studies, Treatment Selection, and Outcomes
Ocular Adnexal Lymphoma: Assessment of a Tumor-Node-Metastasis Staging System
Novel targeted therapies in acute lymphoblastic leukemia
The phosphatidylinositol 3-kinases (PI3K) inhibitor GS-1101 synergistically potentiates histone deacetylase inhibitor-induced proliferation inhibition and apoptosis through the inactivation of PI3K and extracellular signal-regulated kinase pathways
Clinical and pharmacologic aspects of blinatumomab in the treatment of B-cell acute lymphoblastic leukemia
Antibody Therapy for Acute Lymphoblastic Leukemia
Adult Lymphoblastic Lymphoma:
De Novo polycythaemia vera arising 5 years following acute myeloid leukemia remission: Suggestion of a chemotherapy resistant JAK2 clone
Single agent lenalidomide induces a response in refractory T-cell posttransplantation lymphoproliferative disorder
Prostacyclin Production in Tryptase and Thrombin Stimulated Human Bladder Endothelial Cells: Effect of Pretreatment With Phospholipase A 2 and Cyclooxygenase Inhibitors
Protease-activated receptor stimulation activates a Ca2+-independent phospholipase A2in bladder microvascular endothelial cells
Measurement of the Motility of Endothelial Cells in Confluent Monolayers
Missing publications? Search for publications with a matching author name.